Mike Kamdar

Mike Kamdar, The Future Of DNA Writing, And The Business Of Biology

DNA synthesis

Home » Emerging technologies » DNA synthesis

Twist Bioscience Identifies Competitive Antibodies for SARS-CoV-2

– Functional Antibodies Identified to S1 Spike Protein and ACE2 Cellular Receptor – May 06, 2020 08:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation...

Molecular Assemblies Appoints Todd C. Peterson to Board of Directors

Twist Bioscience Expands Flexibility of Clonal Genes for Pharmaceutical, Biotechnology and Industrial Chemical Research

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (Nasdaq: TWST) today announced the enhanced Twist Clonal Genes product line with the expansion of preparation quantities, delivery...

SynBioBeta Live: COVID-19 antibodies roundtable

SynBioBeta 2019 Investor Panel

SynBioBeta Live: Investing in times of turmoil, neurotech and happiness

SGI-DNA is now Codex

Twist Bioscience Partners with Vanderbilt University Medical Center to Supply Critical Products and Identify Antibody Therapeutics for COVID-19

Evonetix Raises $30 Million USD (£23 Million GBP)

DNA Script Presents New Data Demonstrating the Feasibility of the Company’s Enzymatic Synthesis Technology

SGI-DNA Equipping Researchers With Critical Tools to Combat Coronavirus Disease (COVID-2019)

IDT launches xGen Prism DNA Library Prep Kit

Twist Bioscience Announces Pricing of Upsized $130.0 Million Public Offering of Common Stock

Emily Leproust

Twist Bioscience Market Cap Up 18% To $1.1B On Settlement Of Legal Dispute With Agilent

Avidea Technologies Utilizes GenScript’s Synthesized Neoantigen Peptides for Novel Personalized Cancer Vaccine

Twist Bioscience Announces Strategic Collaboration With Schrödinger for Drug Discovery